BiotechTube
Home/Palvella Therapeutics/Wes Kaupinen
WK

Wes Kaupinen

Founder, Chairman & CEO

Palvella Therapeutics

Therapeutic Areas

DermatologyRare Genetic Diseases

Palvella Therapeutics Pipeline

DrugIndicationPhase
QTORIN 3.9% Rapamycin Anhydrous GelPachyonychia Congenita (PC)Phase 3

Leadership Team at Palvella Therapeutics

RB
Robert Buck, PhD
Founder & Chief Scientific Officer
JT
Jay T. Backstrom, MD, MPH
Chief Medical Officer
PB
Patrick Burnett, MD, PhD
Chief Development Officer
MW
Matthew W. Gantz
Chief Financial Officer
View full Palvella Therapeutics profile